Abstract
Background
In cases of papillary thyroid carcinoma (PTC), lymph nodes are a typical site of metastasis. Extrathyroidal tissue involvement in differentiated thyroid carcinoma causes the disease to progress and affects the patients’ treatment options. Papillary thyroid carcinoma (PTC) is the common type in differentiated thyroid carcinoma (DTC), the other type is follicular thyroid carcinoma (FTC). Ectopic sites, such as intrathyroidal lymph node invasion in classical papillary thyroid malignancy, are extremely uncommon. It can be difficult to detect an intrathyroidal lymph node (ITLN) during a histopathological test, but it is important to do so since it affects the stage of the disease and subsequent treatment.
Case presentation
We present the case of a 63-year-old woman who presented with multinodular goitre and underwent total thyroidectomy. She was diagnosed with aberrant intrathyroidal lymph node metastases during pathological testing, resulting in an upgrade in treatment. Owing to the exceptionally unusual ectopic position of lymph node metastasis, in this case, there is a risk of diagnostic and therapeutic misinterpretation. This patient was treated with high-dose radioactive iodine in view of lymph node metastases.
Conclusions
Identification of ITLN by imaging characteristics is sometimes difficult, being often an intraoperative discovery and histopathological correlation that lead to upstage the disease and alter the final management.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Wan Abdul Rahman, Wan Faiziah 2 ; Yahya, Maya Mazuwin 3 ; Mat Nawi, Nor Azwani 4 ; Suhaimi, Nurul Shamimi 4 ; Mat Nawi, Norazlina 5
1 Universiti Sains Malaysia, Department of Family Medicine, Kota Bharu Kelantan, Malaysia (GRID:grid.11875.3a) (ISNI:0000 0001 2294 3534); Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kota Bharu Kelantan, Malaysia (GRID:grid.428821.5) (ISNI:0000 0004 1801 9172)
2 Universiti Sains Malaysia, Department of Pathology, School of Medical Sciences, Kota Bharu Kelantan, Malaysia (GRID:grid.11875.3a) (ISNI:0000 0001 2294 3534); Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kota Bharu Kelantan, Malaysia (GRID:grid.428821.5) (ISNI:0000 0004 1801 9172)
3 Universiti Sains Malaysia, Department of Surgery, School of Medical Sciences, Kota Bharu Kelantan, Malaysia (GRID:grid.11875.3a) (ISNI:0000 0001 2294 3534); Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kota Bharu Kelantan, Malaysia (GRID:grid.428821.5) (ISNI:0000 0004 1801 9172)
4 Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kota Bharu Kelantan, Malaysia (GRID:grid.428821.5) (ISNI:0000 0004 1801 9172)
5 Universiti Sains Malaysia (Health Campus), Department of Nuclear Medicine, Oncology and Radiotherapy, School of Medical Sciences, Kelantan, Malaysia (GRID:grid.11875.3a) (ISNI:0000 0001 2294 3534); Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kota Bharu Kelantan, Malaysia (GRID:grid.428821.5) (ISNI:0000 0004 1801 9172)





